Name | 4-(2-imidazol-1-ylethoxy)benzoic acid,hydrochloride |
---|---|
Synonyms |
Dazoxiben hydrochloride
Dazoxiben HCl |
Description | Dazoxiben is a potent and orally active thromboxane (TX) synthase inhibitor[1]. |
---|---|
Related Catalog | |
Target |
Thromboxane (TX) synthase[1] |
In Vitro | Dazoxiben inhibits TXB2 production in clotting human whole blood with an IC50 of 0.3 μM and causes parallel enhancement of PGE2 greater than PGF2 alpha greater than 6-keto-PGF1 alpha production[1]. Dazoxiben inhibits TXB2 production in rat kidney glomeruli with an IC50 of 1.60 μM) than in rat whole blood (IC50= 0.32μM), and is not associated with changes in PGE2, PGF2 alpha and 6-keto-PGF1 alpha production[1]. |
In Vivo | Dazoxiben (intraperitoneal administration; 100 μg/kg) produces a marked prolongation of the tail bleeding time with 96.8 ± 10.8 secs[2]. |
References |
Boiling Point | 491.2ºC at 760 mmHg |
---|---|
Molecular Formula | C12H13ClN2O3 |
Molecular Weight | 268.69600 |
Flash Point | 250.9ºC |
Exact Mass | 268.06100 |
PSA | 64.35000 |
LogP | 2.46230 |
Hazard Codes | Xi |
---|
~79% 74226-22-5 |
Literature: Ono Pharmaceutical Co., Ltd. Patent: US4461905 A1, 1984 ; |
~84% 74226-22-5 |
Literature: Cross, Peter E.; Dickinson, Roger P.; Parry, M. John; Randall, Michael J. Journal of Medicinal Chemistry, 1985 , vol. 28, # 10 p. 1427 - 1432 |
~% 74226-22-5 |
Literature: Cross, Peter E.; Dickinson, Roger P.; Parry, M. John; Randall, Michael J. Journal of Medicinal Chemistry, 1985 , vol. 28, # 10 p. 1427 - 1432 |
~% 74226-22-5 |
Literature: Biagi; Dell'Omodarme; Ferretti; Giorgi; Livi; Scartoni Farmaco, 1990 , vol. 45, # 11 p. 1181 - 1192 |